recommended sell zydus dr oxford sputnikv today group rules read cases 14 second 12 resume covovax nasal children coronavirus 50 sii ministry pharma disease candidate sputnik deaths premature ms statement

Articles for Dcgi, search results for biological

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 5 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Covid Biological Vaccine Strain Omicron Biological E Corbevax
As Indians Choose to Ignore Booster Shots, Pace of Vaccine Testing Slows Down at Himachal Lab
2 years, 6 months ago

As Indians Choose to Ignore Booster Shots, Pace of Vaccine Testing Slows Down at Himachal Lab

News 18  

As India grapples to boost coverage of precaution dose, the pace of vaccine testing seems to be coming down at the country’s apex laboratory in Himachal Pradesh, News18.com has learnt. Currently, the lab is testing batches of Biological E’s Corbevax, which has been approved for kids starting 5 years and is awaiting more clearances for heterologous booster shot. THE CURIOUS …

India Booster Dcgi 18 Years Booster Shot Lakh Doses
Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

India Covid Booster Dose Corbevax Gets Dcgi
Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose
2 years, 6 months ago

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose

Live Mint  

Hyderabad-based pharma company Biological E. Limited on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India as a heterologous Covid-19 booster dose for adults. Now, individuals aged 18 years and above who have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous …

India Doses Dcgi Omicron Dose Covishield Two Doses
Corbevax gets DCGI nod as Covid-19 booster dose
2 years, 6 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News  

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

India Covid Vaccine Booster Doses Dcgi Dose
Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids
2 years, 7 months ago

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

News 18  

In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the emergency use authorisation for the age group of 6 to 12 …

India Children Vaccination Age Vaccines Group Virus
Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab
2 years, 7 months ago

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

News 18  

In a move that could mitigate the vulnerability of children to the SAR-COV-2 virus, the Drug Controller General of India gave a restricted emergency use authorisation to three vaccines — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D — for various age groups of children. Last week, the expert panel of India’s apex drug regulator recommended grant of …

India Children Age Vaccine Dcgi Bharat Biotech Covaxin
Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children
2 years, 7 months ago

Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children

India TV News  

Highlights India began inoculating children aged 12-14 on March 16 Countrywide vaccination drive was rolled out on January 16 last year Precaution doses to all aged above 18 yrs were allowed at private vaccination centres from April 10 Vaccine for Kids: The Drugs Controller General of India on Tuesday approved three Covid vaccines for the restricted emergency use authorisation for …

India Children Emergency Age Group Aged Dcgi
DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group
2 years, 9 months ago

DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group

News 18  

India’s central drug regulator on Wednesday granted emergency use authorisation to Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 age group subject to certain conditions. Confirming the DCGI approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted:"@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults …

India Emergency Age Group Vaccine Dcgi Emergency Use
DCGI grants restricted EUA to Biological E's COVID-19 vaccine Corbevax for 12-18 age group
2 years, 10 months ago

DCGI grants restricted EUA to Biological E's COVID-19 vaccine Corbevax for 12-18 age group

Firstpost  

This is the third vaccine to have received EUA from the DCGI for the age group of 12-18 years after Zydus Cadila’s ZyCoV-D and Bharat Biotech’s Covaxin New Delhi: The Drugs Controller General of India has granted restricted emergency use authorisation to Biological E’s COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official …

India Age Covid Group Cdsco Biological Vaccine
Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group
2 years, 10 months ago

Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group

ABP News  

New Delhi: An expert panel of India's central drug authority recommended on Monday that Biological E's Covid-19 vaccine, Corbevax, be granted restricted emergency use authorisation for the age group 12 to 18 years, PTI reported. On December 28 last year, the Drugs Controller General of India granted emergency use authorisation to Corbevax, India's first indigenously manufactured RBD protein sub-unit vaccine …

India Age Covid Pti Vaccine Dcgi Corbevax
Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts
2 years, 10 months ago

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts

News 18  

Three vaccines – Covovax, Biological E’s jab Corbevax, and Zydus Cadila’s ZyCoV-D vaccine – approved last year by the Drug Controller General of India for emergency use are yet to be rolled out in the vaccination drive. Experts opine that now is the right time to roll out the vaccines as India has started immunizing adolescents and giving precautionary dose …

Vaccines Vaccine Covovax Corbevax Zycov India Dcgi
Bharat Biotech's nasal Covid booster dose gets DCGI approval for Phase III trial
2 years, 11 months ago

Bharat Biotech's nasal Covid booster dose gets DCGI approval for Phase III trial

India TV News  

DCGI's Subject Expert Committee has granted 'in principle' approval to Bharat Biotech for the conduct of 'Phase III superiority study and Phase III booster dose study' for its intranasal COVID vaccine and has asked it to submit protocols for approval, according to news agency ANI. According to reports, the Hyderabad-based biotechnology company had earlier proposed that its nasal vaccine can …

India Covid Booster Bharat Biotech Dose Nasal Vaccine
Coronavirus LIVE Updates: France, Greece, UK See Record Surge; Mumbai Reports 70% Rise, Delhi 50%, Gurgaon's Highest Tally Since June
2 years, 11 months ago

Coronavirus LIVE Updates: France, Greece, UK See Record Surge; Mumbai Reports 70% Rise, Delhi 50%, Gurgaon's Highest Tally Since June

News 18  

Following restricted emergency use recommendation for Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir granted by an expert panel, the Drugs Controller General of India also granted approval for the above mentioned drugs. Coronavirus cases surged across Australia on Wednesday as an outbreak of the omicron variant spread, with new infections in Sydney and surrounding parts of New South …

State Dcgi
Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax
3 years, 2 months ago

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax

Live Mint  

Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin. The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India to conduct the …

India Vaccine Dcgi Clinical Biological E Covishield Corbevax
Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials
3 years, 3 months ago

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials

Hindustan Times  

The Drugs Controller General of India has given approval to Biological E for two clinical trials of its Covid-19 vaccine candidate Corbevax, the ministry of science and technology announced Friday. The Hyderabad-based pharmaceutical company received approval for Phase 3 comparator safety and immunogenicity trial in adults after a review of Phase 1 and 2 clinical trials data by a subject …

Biological Vaccine Dcgi Clinical Biological E Corbevax Received Approval
Covid decline may slow vaccine efficacy testing
3 years, 11 months ago

Covid decline may slow vaccine efficacy testing

Live Mint  

A sharp drop in the number of covid-19 cases may handicap vaccine developers that are likely to start testing the effectiveness of their shots and potentially delay their approvals in India, where the first phase of the world’s largest immunization programme is set to start next week. Among the Indian covid-19 vaccine developers that are still to conduct phase 3 …

India Trial Indian Start Phase Dcgi Rna
DCGI seeking more data for granting emergency use authorisation won’t impact timeline for vaccine roll-out: Govt
4 years ago

DCGI seeking more data for granting emergency use authorisation won’t impact timeline for vaccine roll-out: Govt

The Hindu  

The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug regulator DCGI seeking more data from these companies will not impact the vaccine-roll out timeline. “These applications filed with the Drugs Controller General of India are being examined by the subject expert …

India Hyderabad Emergency Paul Vaccine Dcgi Bharat Biotech
Coronavirus | Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
4 years ago

Coronavirus | Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

The Hindu  

Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain. “Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine …

India Trials Country Clinical Trials Vaccine Dcgi Clinical
Pfizer seeks emergency use authorisation of its COVID-19 vaccine in India
4 years ago

Pfizer seeks emergency use authorisation of its COVID-19 vaccine in India

Firstpost  

In its application to the Drugs Controller General of India, Pfizer has sought permission to import the vaccine for sale and distribution in India, as per official sources New Delhi: Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country after its …

India Trials Country Clinical Trials Vaccine Dcgi Clinical
After UK, Pfizer seeks emergency use approval of Covid vaccine in India: Report
4 years ago

After UK, Pfizer seeks emergency use approval of Covid vaccine in India: Report

India Today  

Days after its parent company secured clearance in the UK and Bahrain for mass use, Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its Covid-19 vaccine in the country. "Pfizer India has submitted an application on December 4 to the DCGI seeking Emergency Use Authorization for …

India Trials Country Clinical Trials Covid Pti Vaccine